Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $32.32 and traded as high as $36.71. Simulations Plus shares last traded at $36.05, with a volume of 151,390 shares changing hands.
Analysts Set New Price Targets
SLP has been the subject of several research reports. BTIG Research decreased their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, October 24th. StockNews.com lowered Simulations Plus from a "hold" rating to a "sell" rating in a research report on Monday, November 4th. Stephens started coverage on Simulations Plus in a research report on Friday, November 15th. They issued an "overweight" rating and a $39.00 target price for the company. KeyCorp increased their target price on Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Finally, William Blair reissued an "outperform" rating on shares of Simulations Plus in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $49.40.
Check Out Our Latest Report on SLP
Simulations Plus Stock Performance
The company has a 50 day moving average price of $31.38 and a 200 day moving average price of $32.27. The company has a market capitalization of $731.68 million, a PE ratio of 91.05 and a beta of 0.83.
Insider Transactions at Simulations Plus
In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 19.40% of the company's stock.
Hedge Funds Weigh In On Simulations Plus
A number of large investors have recently bought and sold shares of SLP. First Horizon Advisors Inc. lifted its holdings in shares of Simulations Plus by 82.6% in the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock worth $26,000 after purchasing an additional 370 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after buying an additional 427 shares during the last quarter. nVerses Capital LLC boosted its holdings in shares of Simulations Plus by 1,100.0% during the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company's stock valued at $38,000 after acquiring an additional 1,100 shares during the period. Johnson Financial Group Inc. bought a new position in shares of Simulations Plus during the fourth quarter worth about $39,000. Finally, Quantbot Technologies LP bought a new stake in Simulations Plus in the 3rd quarter valued at about $59,000. Institutional investors own 78.08% of the company's stock.
About Simulations Plus
(
Get Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles
Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
